Nascent Biotech, Inc. (NBIO)
OTCMKTS · Delayed Price · Currency is USD
0.0002
-0.0003 (-60.00%)
Jul 7, 2026, 9:30 AM EST
Nascent Biotech Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
34.57K
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | - | - | - |
| Mar 31, 2023 | - | - | - |
| Mar 31, 2022 | 1.00M | 250.00K | 33.33% |
| Mar 31, 2021 | 750.00K | - | - |
| Mar 31, 2020 | - | - | - |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Scorpius Holdings | 1.72M |
| Regen BioPharma | 236.56K |
| U.S. Stem Cell | 82.05K |
| Health Sciences Group | 69.31K |
| Affymax | 42.00K |
| NanoLogix | 1.27K |
Nascent Biotech News
- 1 year ago - Nascent Biotech receives delinquency notification related to delayed filing - TheFly
- 2 years ago - Nascent Biotech recaps presentation at Emerging Growth Conference - TheFly
- 2 years ago - Nascent Biotech Presents at the July Emerging Growth Conference - Accesswire
- 2 years ago - Nascent Biotech embarks on fresh manufacturing run for pritumumab - TheFly
- 2 years ago - Nascent Prepares for Pivotal Phase II Research with Fresh Manufacturing Run - Accesswire
- 2 years ago - Nascent Biotech collaborates with HypoSpray on transdermal delivery system - TheFly
- 2 years ago - Nascent Collaborates With Hypospray Pharma on Proprietary Transdermal Delivery System - Accesswire
- 2 years ago - Nascent Biotech, Manhattan BioSolutions partner to explore pritumumab conjugates - TheFly